Chronic obstructive pulmonary disease

Current Anaesthesia and Critical Care

Volumn 14, Issue 2, 2003, Pages 74-80

  Singh, S ^a,b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Chronic obstructive smoking; Intermittent positive pressure ventilation bronchodilator agents; Oxygen inhalation therapy; Pulmonary disease; Pulmonary ventilation

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; GLUCOCORTICOID; HELIUM; INFLUENZA VACCINE; IPRATROPIUM BROMIDE; LIVE VACCINE; MUCOLYTIC AGENT; OXYGEN; PLACEBO; SALBUTAMOL; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ACUTE RESPIRATORY FAILURE; ARTIFICIAL VENTILATION; AWARENESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; HEALTH CARE COST; HEALTH PRACTITIONER; HUMAN; LUNG FUNCTION; LUNG INSUFFICIENCY; MORTALITY; PATIENT EDUCATION; PATIENT MONITORING; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; RESPIRATORY AIRFLOW; REVIEW; RISK FACTOR; SIDE EFFECT; SMOKING; SPIROMETRY;

EID: 0042527448     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-7112(03)00032-2     Document Type: Article

References (45)

1. Pauwels R A, Buist A S, Calverley P M, Jenkins C R, Hurd S S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163(5): 1256-1276 (Also available at http://www.goldcopd.com).
2. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995; Nov; 152(5 Pt 2): S77-S121 (Also available at http://www.thoracic.org).
3. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52 (Suppl 5): S1-S28.
4. The Cochrane Library. Oxford: Update Software, 2002 [cited 2002 Dec 12]. Available from: URL: http://www.update-software.com/Cochrane.
5. Kidney J, McManus T, Coyle P V. Exacerbations of chronic obstructive pulmonary disease. Thorax 2002; 57(9): 753-754.
6. Connors Jr A F, Dawson N V, Thomas C, et al. The Support Investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med 1996; 154: 959-967.
7. Gonzales D H, Nides M A, Ferry L H et al. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study. Clin Pharmacol Ther 2001; 69(6): 438-444.
8. Donaldson G C, Seemungal T A, Bhowmik A, Wedzicha J A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57(10): 847-852.
9. Sestini P, Renzoni E, Robinson S, Poole P, Ram F S F. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
10. Appleton S, Poole P, Smith B, Veale A, Bara A. Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitation (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software, 2002:
11. McCrory D C, Brown C D. Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease (Cochrane review). In: The Cochrane Library, Issue 4, Oxford: Update Software, 2002.
12. Donohue J F, van Noord J A, Bateman E D et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122(1): 47-55.
13. van Noord J A, Bantje T A, Eland M E, Korducki L, Cornelissen P J. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group. Thorax 2000 Apr; 55(4): 289-294.
14. Burge P S. EUROSCOP, ISOLDE and the Copenhagen city lung study. Thorax 1999; 54(4): 287-288.
15. Burge P S, Calverley P M, Jones P W, Spencer S, Anderson J A, Maslen T K. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000 320(7245): 1297-1303.
16. van Grunsven P M, van Schayck C P, Derenne J P et al. Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax 1999; 54(1): 7-14.
17. Poole P J, Black P N. Mucolytic agents for chronic bronchitis (Cochrane Review). In: The Cochrane Library, Issue 4, Oxford: Update Software, 2002.
18. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981; 1(8222): 681-686.
19. Long term oxygen and advanced chronic bronchitis. Lancet 1981; 1(8222): 701-702.
20. Lacasse Y, Brosseau L, Milne S et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 4, Oxford: Update Software, 2002.
21. Poole P J, Chacko, E, Wood-Baker R W B, Cates C J. Influenza vaccine for patients with chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, issue, Oxford: Update Software, 2002.
22. Smith B, Appleton S, Adams R, Southcott A, Ruffin R. Home care by outreach nursing for chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library. Issue 4. Oxford: Update Software, 2002.
23. Meecham Jones D J, Paul E A, Jones P W, Wedzicha J A. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med 1995; 152(2): 538-544.
24. Sethi S, Evans N, Grant B J, Murphy T F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347(7): 465-471.
25. Seemungal T, Harper-Owen R, Bhowmik A et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164(9): 1618-1623.
26. 2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis 1980; 122(5): 747-754.
27. Gomersall C D, Joynt G M, Freebairn R C, Lai C K, Oh T E. Oxygen therapy for hypercapnic patients with chronic obstructive pulmonary disease and acute respiratory failure: a randomized, controlled pilot study. Crit Care Med 2002; 30(1): 113-116.
28. Rodrigo G, Pollack C, Rodrigo C, Rowe B, Walters E H. Heliox for treatment of exacerbations of chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 4, Oxford: Update Software, 2002.
29. Wood-Baker R, Walters E H, Gibson P. Oral corticosteroids for acute exacerbations of chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 4, Oxford: Update Software, 2002.
30. Niewoehner D E, Erbland M L, Deupree R H et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999; 340(25): 1941-1947.
31. Davies L, Angus R M, Calverley P M. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999; 354(9177): 456-460.
32. Greenstone M. Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
33. Brochard L, Mancebo J, Wysocki M et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333(13): 817-822.
34. Plant P K, Owen J L, Elliott M W. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000; 355(9219): 1931-1935.
35. Keenan S P, Kernerman P D, Cook D J, Martin C M, McCormack D, Sibbald W J. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis. Crit Care Med 1997; 25(10): 1685-1692.
36. BTS Guideline. Non-invasive ventilation in acute respiratory failure. Thorax 2002; 57(3): 192-211.
37. Evans T W. International Consensus Conferences in Intensive Care Medicine: non-invasive positive pressure ventilation in acute respiratory failure. Organised jointly by the American Thoracic Society, the European Respiratory Society, the European Society of Intensive Care Medicine, and the Societe de Reanimation de Langue Francaise, and approved by the ATS Board of Directors, December 2000. Intensive Care Med 2001; 27(1): 166-178.
38. Moran J L, Green J V, Homan S D, Leeson R J, Leppard P I. Acute exacerbations of chronic obstructive pulmonary disease and mechanical ventilation: a reevaluation. Crit Care Med 1998; 26(1): 71-78.
39. Breen D, Churches T, Hawker F, Torzillo P J. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long term follow up study. Thorax 2002; 57(1): 29-33.
40. Fagon J Y, Chastre J, Hance A J, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94(3): 281-288.
41. Esteban A, Frutos F, Tobin M J et al. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med 1995; 332(6): 345-350.
42. Brochard L, Rauss A, Benito S et al. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care Med 1994; 150(4): 896-903.
43. Nourdine K, Combes P, Carton M J, Beuret P, Cannamela A, Ducreux J C. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Med 1999; 2S(6): 567-573.
44. Nava S, Ambrosino N, Clini E et al. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial. Ann Intern Med 1998; 128(9): 721-728.
45. Girault C, Daudenthun I, Chevron V, Tamion F, Leroy J, Bonmarchand G. Noninvasive ventilation as a systematic extubation and weaning technique in acute-on-chronic respiratory failure: a prospective, randomized controlled study. Am J Respir Crit Care Med 1999; 160(1): 8692.